de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

The Type III Secretion Effector NleE Inhibits NF-kappa B Activation

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons81802

Bartfeld,  Sina
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons82047

Meyer,  Thomas F.
Department of Molecular Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Locator
There are no locators available
Fulltext (public)

PLoS_Pathogen_2010_6_e1000743.pdf
(Publisher version), 996KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Nadler, C., Baruch, K., Kobi, S., Mills, E., Haviv, G., Farago, M., et al. (2010). The Type III Secretion Effector NleE Inhibits NF-kappa B Activation. PLoS Pathogens, 6(1): e1000743.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-C042-1
Abstract
The complex host-pathogen interplay involves the recognition of the pathogen by the host's innate immune system and countermeasures taken by the pathogen. Detection of invading bacteria by the host leads to rapid activation of the transcription factor NF-kappa B, followed by inflammation and eradication of the intruders. In response, some pathogens, including enteropathogenic Escherichia coli (EPEC), acquired means of blocking NF-kappa B activation. We show that inhibition of NF-kappa B activation by EPEC involves the injection of NleE into the host cell. Importantly, we show that NleE inhibits NF-kappa B activation by preventing activation of IKK beta and consequently the degradation of the NF-kappa B inhibitor, I kappa B. This NleE activity is enhanced by, but is not dependent on, a second injected effector, NleB. In conclusion, this study describes two effectors, NleB and NleE, with no similarity to other known proteins, used by pathogens to manipulate NF-kappa B signaling pathways.